Cough, Cold and Allergy (Hay Fever) Remedies

While in 2022 Pakistan largely put the disruptions caused by COVID-19 behind it, there were other challenges. Spiralling inflation, massive devaluation of the Pakistani rupee against major world currencies and catastrophic floods, which left hundreds…

With almost all Coronavirus (COVID-19) restrictions loosened or lifted, including the mandatory wearing of face masks in public, ailments and infections like coughs, colds and flu started to increase in frequency and penetration at the end of the…

In value share terms, cough, cold and allergy (hay fever) remedies remains the largest OTC category in Germany. The category suffered in 2020 due to changes in lifestyles during the pandemic, as various restrictions to control the spread of COVID-19,…

While cough, cold and allergy (hay fever) remedies is expected to register healthy current value growth in 2022, constant value growth is expected to fall. The war in Ukraine had led to an energy crisis, which in return is leading to high inflation.…

As pre-pandemic patterns returned towards the end of the end of 2021 and masking became non-mandatory, seasonal pathologies such as coughs, colds, sore throats and allergies also made a comeback among French consumers. A mild and rainy winger over…

In 2022 the COVID-19 pandemic has been under better control allowing for the relaxation of lockdown measures, social distancing rules and so on. This has resulted in consumers leading more active lives and getting into closer contact with others,…

With the lockdown in Taiwan being lifted in 2022, consumers’ lives are normalising. This is leading to greater social interaction and greater circulating of common coughs and colds. In addition, the major symptom of the omicron variant of COVID-19 is…

Cases of influenza increased and there was a return to growth for COVID-19 infections in Brazil during the first half of 2022. This was due to the return of students to public and private schools, in addition to the hybrid work regime adopted by…

Historically, Algerian consumers have regarded coughs, colds and allergies as easily treated, everyday inconveniences, and generally choose to self-medicate with OTC products rather than seek out medical advice. However, the pandemic has pushed this…

Towards the end of 2021 and in the first half of 2022, Serbian consumers returned to their pre-Coronavirus (COVID-19) lifestyles, including visiting public places, not wearing face masks and relaxed social distancing adherence, returning to…

Cough, cold and allergy (hay fever) remedies is projected to see a very strong performance in retail volume and current value growth terms over 2022. This follows on from the fast 2021 rebound in sales from Coronavirus (COVID-19)-induced declines in…

All cough, cold and allergy (hay fever) remedies categories contracted in volume terms in 2021. This was partly the result of stockpiling that occurred during the initial stages of the pandemic in 2020, but also because the incidence of flu, common…

Over 2020-2021, the incidence of common colds, coughs and flu in Kazakhstan was lower than usual due to lockdowns, social distancing and other policies adopted to curb the spread of COVID-19. However, most mandated pandemic mitigation measures have…

The reopening of the country, along with removed restrictions and the surge in Omicron cases led to a rise in sales of cough, cold and allergy (hay fever) remedies in the Philippines over the winter of 2021/2022, particularly during holiday periods…

Cough, cold and allergy (hay fever) remedies is the largest category of consumer health in Thailand in current value terms with it also having a fragmented competitive landscape with a large number of players vying for share. As such, players are…

Retail sales of cough, cold and allergy (hay fever) remedies demonstrated vastly accelerated growth in current value terms in 2022, following a return to pre-pandemic lifestyles. As masks were abandoned and consumers returned to their normal daily…

Despite strong growth in 2020 due to COVID-19 and purchases of cough remedies and nasal sprays for use during self-quarantine, cough, cold and allergy (hay fever) remedies retained healthy growth rates in 2021 and will see further increases in 2022.…

Cough, cold and allergy (hay fever) remedies are expected to register high current value growth in 2022, but constant value growth is expected to fall slightly. Azerbaijan’s proximity to both Ukraine and Russian is expected to create a lot of…

Cough, cold and allergy (hay fever) remedies has become the centre of focus again as COVID-19 restrictions are eased and consumers remain alert for any symptoms of cough, cold and flu. Consumers tend to look to use cough, cold and allergy (hay fever)…

While cough, cold and allergy (hay fever) remedies is expected to register an increase in current value sales, though constant value sales are expected to fall slightly in 2022. Rising inflation as a result of the energy crisis stemming from the war…